Oct 11 2024 |
McDermott+ Check-Up (Special Regulatory Edition): October 11, 2024 |
McDermott Will & Schulte LLP |
Oct 11 2024 |
California and Colorado Establish Protections for Neural Data |
ArentFox Schiff LLP |
Oct 11 2024 |
California's New Health Care Workers Minimum Wage is Finally Set to Increase |
Polsinelli PC |
Oct 11 2024 |
Trending in Telehealth: September 17 – 30, 2024 |
McDermott Will & Schulte LLP |
Oct 11 2024 |
Three More States Sue TikTok Alleging Harm to Young Users |
Robinson & Cole LLP |
Oct 11 2024 |
US Supreme Court Declines to Consider AKS ‘Willfulness’ Question |
ArentFox Schiff LLP |
Oct 11 2024 |
Health Law Diagnosed – Women Leaders in Health Care: Investing in Women’s Health [Podcast] |
Mintz |
Oct 11 2024 |
Canada Begins Public Consultations on Initiatives Supporting CEPA Amendments |
Bergeson & Campbell, P.C. |
Oct 11 2024 |
The Evolution of AI in Healthcare: Current Trends and Legal Considerations |
Norris McLaughlin P.A. |
Oct 11 2024 |
Many New Laws for the Land of Many Lakes: What Minnesota Employers Need to Know |
Epstein Becker & Green, P.C. |
Oct 10 2024 |
Federal Court Enters Consent Decree Against Rizo Lopez Foods Linked to Listeria Outbreak |
Keller and Heckman LLP |
Oct 10 2024 |
California Health Care Minimum Wage Is Back |
Jackson Lewis P.C. |
Oct 10 2024 |
Employers in England, Scotland, and Wales Have New Obligation to Prevent Sexual Harassment |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Oct 10 2024 |
HHS Announces Settlement Agreement with Washington Chain of Eye and Skin Clinics Following Ransomware Investigation |
Hunton Andrews Kurth |
Oct 10 2024 |
Health-e Law Episode 13: Overcoming Challenges to Innovation in Preventative Care with Steven Collens of MATTER [Podcast] |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 10 2024 |
New California Law Expands Fertility Coverage by Large Group Insurance Plans |
Greenberg Traurig, LLP |
Oct 10 2024 |
Competition Currents | October 2024 |
Greenberg Traurig, LLP |
Oct 10 2024 |
Final Mental Health Parity Rules Released: Next Steps for Employers |
Epstein Becker & Green, P.C. |
Oct 9 2024 |
This Week in 340B: October 1 – 7, 2024 |
McDermott Will & Schulte LLP |
Oct 9 2024 |
The Wait Is Over: Revised CMS Enrollment Form Puts SNF Ownership Under a Microscope |
K&L Gates LLP |
Oct 9 2024 |
HHS Imposes Civil Penalty Against Interstate Network of Medical Providers Following Ransomware Attack |
Hunton Andrews Kurth |
Oct 9 2024 |
OHRP Workshop Highlights Artificial Intelligence Uses, Concerns in Human Research |
Mintz |
Oct 9 2024 |
HHS-OIG Issues Unfavorable Opinion Regarding Medicare Advantage, Gainshare Payments to Employers |
Barnes & Thornburg LLP |
Oct 9 2024 |
EPA Seeks Public Comment on Manufacture of Certain PFAS During Fluorination of HDPE and Other Plastic Containers |
Bergeson & Campbell, P.C. |
Oct 9 2024 |
No. 7 OSHA Can Issue Citations for Unsafe Work Conditions That Do Not Violate Any Specific OSHA Standard |
Bradley Arant Boult Cummings LLP |
Oct 8 2024 |
The Power of Three: Three Whistleblowers Rewarded for Reporting Unlawful Kickbacks and Laboratory Fraud Scheme |
Tycko & Zavareei LLP |
Oct 8 2024 |
General Hospital Cybersecurity Requirements Take Effect in New York |
Greenberg Traurig, LLP |
Oct 8 2024 |
Understanding AB 1775: The Future of Cannabis Cafes in California |
ArentFox Schiff LLP |
Oct 8 2024 |
Webinar Replay: Unpacking the Final Mental Heath Parity Regulations |
McDermott Will & Schulte LLP |
Oct 8 2024 |
Hiring Across the 49th Parallel: Traps for the Unwary for Cross-Border US-Canada Hires (Part II) |
Mintz |
Oct 8 2024 |
Employment Tip of the Month – October 2024 |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Oct 8 2024 |
Lessons Learned: Wisdom from Professional Licensing Attorneys |
Ward and Smith, P.A. |
Oct 7 2024 |
Relator, No More? Florida Federal Court Declares Qui Tam Provisions of False Claims Act Unconstitutional, with Potentially Broad Implications for Government Fraud Litigation |
Proskauer Rose LLP |
Oct 7 2024 |
IRS Announces Broad Filing and Payment Extensions to Hurricane Victims; Alabama DOR Offers “Case-by-Case” Relief |
Bradley Arant Boult Cummings LLP |
Oct 7 2024 |
GLP-1 Drugs: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Shortage List |
Foley & Lardner LLP |